Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC
Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC
Not yet recruiting · NCT07724886 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Not yet recruiting | Not applicable | 2026-08-03 | NCT07724886 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese University of Hong Kong | 480 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| North District Hospital | Sheung Shui | Hong Kong | 6 |
| Prince of Wales Hospital | Hong Kong | Hong Kong | 81 |